Healthcare provider profile · identity verified

Wendell Bryan Williams, MD

Family Practice · OAKLAND, CA · NPI 1093703357

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	392	137
Amlodipine Besylate	Amlodipine Besylate	316	102
Lisinopril	Lisinopril	255	91
Albuterol Sulfate Hfa	Albuterol Sulfate	236	108
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	201	50
Losartan Potassium	Losartan Potassium	192	70
Levothyroxine Sodium	Levothyroxine Sodium	174	57
Gabapentin	Gabapentin	154	59
Atenolol	Atenolol	138	46
Metformin Hcl Er	Metformin Hcl	137	57
Fluticasone Propionate	Fluticasone Propionate	132	56
Furosemide	Furosemide	132	56
Tamsulosin Hcl	Tamsulosin Hcl	123	50
Metformin Hcl	Metformin Hcl	121	43
Ozempic	Semaglutide	118	27
Simvastatin	Simvastatin	117	38
Omeprazole	Omeprazole	99	45
Pantoprazole Sodium	Pantoprazole Sodium	87	31
Hydralazine Hcl	Hydralazine Hcl	85	32
Hydrochlorothiazide	Hydrochlorothiazide	85	35
Oxycodone Hcl	Oxycodone Hcl	84	13
Famotidine	Famotidine	83	38
Alvesco	Ciclesonide	79	42
Pravastatin Sodium	Pravastatin Sodium	77	26
Ibuprofen	Ibuprofen	76	37
Metoprolol Tartrate	Metoprolol Tartrate	72	33
Allopurinol	Allopurinol	71	24
Finasteride	Finasteride	64	23
Trazodone Hcl	Trazodone Hcl	62	27
Wixela Inhub	Fluticasone Propion/Salmeterol	61	19
Glipizide	Glipizide	60	19
Prednisone	Prednisone	58	33
Morphine Sulfate Er	Morphine Sulfate	57	suppressed
Cephalexin	Cephalexin	55	42
Montelukast Sodium	Montelukast Sodium	55	19
Triamcinolone Acetonide	Triamcinolone Acetonide	52	22
Jardiance	Empagliflozin	51	16
Metoprolol Succinate	Metoprolol Succinate	49	18
Alendronate Sodium	Alendronate Sodium	47	17
Carvedilol	Carvedilol	47	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	39
Lorazepam	Lorazepam	46	22
Pradaxa	Dabigatran Etexilate Mesylate	46	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	16
Terazosin Hcl	Terazosin Hcl	43	15
Azithromycin	Azithromycin	42	35
Hydrocortisone	Hydrocortisone	42	26
Sertraline Hcl	Sertraline Hcl	41	13
Acetaminophen-Codeine	Acetaminophen With Codeine	39	17
Meloxicam	Meloxicam	38	24
Mirtazapine	Mirtazapine	38	11
Topiramate	Topiramate	38	13
Doxycycline Monohydrate	Doxycycline Monohydrate	37	33
Hydromorphone Hcl	Hydromorphone Hcl	37	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	37	27
Duloxetine Hcl	Duloxetine Hcl	36	14
Pregabalin	Pregabalin	36	14
Spiriva Respimat	Tiotropium Bromide	36	12
Potassium Chloride	Potassium Chloride	35	15
Amoxicillin	Amoxicillin	34	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	12
Glipizide Er	Glipizide	32	12
Rosuvastatin Calcium	Rosuvastatin Calcium	32	11
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Mupirocin	Mupirocin	31	26
Diclofenac Sodium	Diclofenac Sodium	30	16
Lovastatin	Lovastatin	30	suppressed
Acyclovir	Acyclovir	29	14
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Ondansetron Odt	Ondansetron	28	17
Breyna	Budesonide/Formoterol Fumarate	27	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Nabumetone	Nabumetone	25	13
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Sucralfate	Sucralfate	25	11
Trospium Chloride	Trospium Chloride	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Clindamycin Hcl	Clindamycin Hcl	23	19
Fluocinonide	Fluocinonide	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	22	22
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Tizanidine Hcl	Tizanidine Hcl	22	13
Colchicine	Colchicine	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Baclofen	Baclofen	17	suppressed
Eliquis	Apixaban	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Temazepam	Temazepam	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	14	13
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Chlorthalidone	Chlorthalidone	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Naproxen	Naproxen	12	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Fentanyl	Fentanyl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Propranolol Hcl	Propranolol Hcl	11	suppressed
Retin-A	Tretinoin	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error